MILTON KEYNES, England, June 8 /PRNewswire/ -- SPEKTOR(R) Forensic Intelligence, a fast and forensically sound data acquisition, analysis and review solution for front line officers from the law enforcement and government communities, has been launched by UK-based forensic computing experts Evidence Talks Ltd.

The portable, easy to use system enables officers with minimal training to preserve data and make informed decisions while ensuring evidential continuity, along with forensic and legal acceptability.

CONSHOHOCKEN, Pennsylvania, June 8 /PRNewswire/ --

Conshohocken-based Quaker Chemical Corporation, a leading global provider of process chemicals, today announced the launch of the new QUINTOLUBRIC(R) website, www.quintolubric.com, to better meet the needs of their customers. The new site has been redesigned with a clearer structure and simplified, user-friendly navigation that makes finding information easier than before. The site also has a totally new graphic look.

LONDON, June 8 /PRNewswire/ -- Survey Shows Many Doctors Find the Management of Atrial Fibrillation Difficult and Patients are Unaware of the Risks, Complexities and Treatment for This Most Common of Heart Rhythm Disorders

Four leading patient and medical associations announced today the formation of AF AWARE (Atrial Fibrillation AWareness And Risk Education), a joint initiative to highlight and address issues that contribute to the growing burden of atrial fibrillation (AF) worldwide.

AF is a common yet under-recognised and poorly understood abnormal heart rhythm that is associated with poor quality of life, substantial numbers of hospitalisations, increased risk of severe and potentially fatal cardiovascular complications such as stroke, as well as death.

BRUSSELS, June 8 /PRNewswire/ -- The 'Excellence in Epilepsy' Journalism Award - an initiative of the International Bureau for Epilepsy (IBE) and UCB - invites journalists from around the world to submit stimulating, informed and compelling news and feature stories on epilepsy.

The award seeks to increase awareness and improve understanding of epilepsy. The closing date for entries and nominations is 30 June, 2009.

To view the Multimedia News Release, please click:

http://www.prnewswire.com/mnr/ucb/36384/

ARMONK, New York, June 8 /PRNewswire/ --

IBM (NYSE: IBM) today announced it has completed the deployment of an infrastructure that will modernize the delivery of government services for the Kingdom of Saudi Arabia. The multi-year eGovernment Service Bus (GSB) project delivers the core communication and security infrastructure for the Yesser eGovernment Program, the Kingdom's long-term modernization of all government services. This program will eventually provide everyone in the Kingdom with access to government services from anyplace and at anytime, replacing the current system of time-consuming, manual processes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO )

HAIFA, Israel, June 7 /PRNewswire/ --

Oil Refineries Ltd. (TASE: ORL.TA) (ORL or the Company), Israel's largest oil refiner, announced today that the Israel Corporation (Israel Corp.) and Israel Petrochemical Enterprises Ltd. (IPE) have completed the signing of a joint control agreement in ORL between the Israel Corp., IPE and Petroleum Capital Holdings (fully owned by IPE) (Petroleum), as well as signed an addendum to the Control Agreement in the Company.

SINGAPORE, June 7 /PRNewswire/ --

- Designed for Technophobes, the Jabra BT2080 is Effortless to use - the Epitome of Simplicity

Jabra, a world leader in innovative headset solutions, has today launched its latest no nonsense handsfree device, the all new Jabra BT2080. Perfect for the day-to-day headset user, the headset solves all the small, fiddly problems that can put users off using a headset, and combines the two outstanding qualities that Jabra is best known for; style and ease of use. Not only will you look good when using it, but you will be sure to master the headset in next to no time.

( Logo: http://www.newscom.com/cgi-bin/prnh/20090318/340540-b )

( Photo: http://www.newscom.com/cgi-bin/prnh/20090607/346072 )

It is a well-known fact that it is much easier to measure a physical quantity than to correctly assess the magnitude of the uncertainty on the measurement: the uncertainty is everything!

A trivial demonstration of the above fact is the following. Consider you are measuring the mass of the top quark (why, I know you do it at least once a week, just to keep mentally fit). You could say you have no idea whatsoever of what the top mass is, but you are capable of guessing, and your best guess is that the top mass is  twice the mass of the W boson: after all, you have read somewhere that the top quark decays into a W boson plus other stuff, so a good first-order estimate is 2x80.4= 160.8 GeV.

BERLIN, June 7 /PRNewswire/ --

Amgen Inc. (Nasdaq: AMGN) today released the results of a new study comparing Nplate(R) (romiplostim) to the medical standard of care (SOC) in non-splenectomised adult patients with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a serious autoimmune disorder characterised by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. The study results show Nplate significantly reduced the incidences of splenectomy and treatment failures in non-splenectomised adult patients with chronic ITP when compared to medical SOC. The results were presented today as an oral presentation at the 14th congress of the European Hematology Association (EHA abstract #1672).